Pharmacy automation manufacturer Kirby Lester has launched a version of one of its tablet counters with streamlined verification software.

AstraZeneca paid $3.2 billion to Amylin Pharmaceuticals Thursday following the latter's acquisition by Bristol-Myers Squibb, AstraZeneca and Bristol said.

Walmart has unveiled its 100th solar-powered store in San Diego.

Green Forest Nutrition recently introduced a line of what it is touting as weight-loss gummies.

Government authorities are working to educate independent pharmacy owners on prescription drug abuse, an independent pharmacy network said.

The National Community Pharmacists Association is slated to host its 114th annual convention and trade exposition this fall in San Diego.

Drug maker Apricus Biosciences will receive regulatory guidance from the Food and Drug Administration in July that will contain feedback concerning the drug maker's plans to seek approval for a nail fungus treatment.

CVS Caremark announced today its partnership with The Miracle Project, a nonprofit organization that creates social skills programs for children with autism through the performing arts, to expand The Miracle Project School Inclusion Program to public schools in San Diego and San Jose, Calif.

Drug maker Amylin Pharmaceuticals has filed for regulatory approval of a drug to treat diabetes and elevated triglycerides in the bloodstream in children and adults with a rare disorder.

The National Community Pharmacists Association has renewed two of its pharmacy niche programs.

The Food and Drug Administration has approved a long-acting injected diabetes drug made by Amylin Pharmaceuticals and Alkermes, the two companies said.

Drug maker Santarus has submitted a new drug application with the Food and Drug Administration for a treatment for ulcerative colitis, the company said.